Weight Loss

A novel glucagon/GLP-1 receptor agonist conferred nearly 15% weight loss at 46 weeks among people with overweight or obesity without type 2 diabetes, according to an industry press release.

Patients with chronic kidney disease and obesity may be at a higher risk for death when experiencing BMI loss at the same time as serum albumin or fat-free mass loss, according to data published in Kidney International Reports.

Adults with type 2 diabetes who switched from liraglutide to semaglutide therapy had greater reductions in HbA1c and body weight at 26 weeks than those who switched to dulaglutide, according to study data from researchers in Japan.

SEATTLE — In this video exclusive, Jonathan D. Leffert, MD, talks with Karl Nadolsky, DO, FACE, DABOM, about the drawbacks of using BMI and the importance of addressing weight stigma and bias when diagnosing and treating obesity.

The FDA recently approved the Medtronic MiniMed 780G system, an insulin pump that uses meal detection technology to automatically adjust basal and bolus insulin needs for people with type 1 diabetes, according to a press release.

SAN DIEGO — Time-restricted feeding offers benefits for weight loss, but it is not superior to other calorie-restriction diets, according to a presenter at the ACP Internal Medicine Meeting.

Bariatric surgery may significantly lower the risk for obesity-related cancers, including breast, colon, liver, pancreatic, ovarian and thyroid, in patients with obesity.

Adults with overweight or obesity and type 2 diabetes achieved a mean weight loss of more than 13% after taking either 10 mg or 15 mg of tirzepatide for 72 weeks, according to topline results from the SURMOUNT-2 trial.

Weight loss of 5% or greater was associated with an increased risk for all-cause mortality among older healthy adults, particularly men, highlighting the importance of monitoring these patients for weight changes, according to researchers.

Participants in behavioral weight-loss programs improved several CV risk factors for at least 5 years after an intervention ended, despite weight regain, compared with low-intensity programs or controls, researchers reported.